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NORMAL tissues have been successfully transplanted in foreign hosts which
have been treated in such a way as to render them tolerant. Such tissues include
skin (Billingham, Brent and Medawar, 1953), thyroid (Woodruff and Boswell,
1954 ; Woodruffand Sparrow, 1958), ovai-ies (Krohn, 1958 ; Martinez, Smith and
Good, 1958), adrenals (Medawar and Russell, 1958), and pituitaries (Martinez
et al., 1958). The homotransplanted glands retain their functional integritv in
the immunologically tolerant hosts: thyroid homografts are able to concentrate
radio-iodine, adrenal homografts can sustain life in adrenalectomized animals
on a salt-deficient diet, ovarian homografts give rise to sexual cycles and, when
orthotopically transplanted, can produce ova from which litterseventually deve-
lop, and pituitary homografts can 'maintain normal growth and normal control
over other endocrine glands.
Acquired tolerance of homografts of normal thymuses has been achieved in
the experiments reported hereby the intravenous inoculation during the neonatal
period ofliving spleen or thymus cells taken from adult mice of the same strain
as theprospectivedonors ofthethymuses. It is nowwell established thatlympho- cytic leukaemia, whether spontaneous or induced, does not usually develop in
the absence of thymus tissue (McEndy, Boon and Furth, 1944 ; Kaplan, 1950
Law and Miller, 1950a, b ; Gross, 1959 ; Levinthal, Buffett and Furth, 1959
Miller, 1959a, b ; 1960b) and that thymus grafting restores the potentiality for
leukaemia development in isologous combinations (Law and Miller, 1950a, b;
Kaplan and Brown, 1954; Miller, 1959b, 1960b). It will be shown in this paper that thymus tissue from genetically susceptible mice can undergo malignant transformation in aforeign but toleranthost, and that a number ofsuchmalignant thymuses can be made to regresscompletely following the inoculation of activated
immunologically competent cells.
MATERIALS AND METHODS
Mice.-Mice of the C3H/PW or C3Hf/PW strain, inbred in our laboratory since their acquisition from Bittner in 1938, show an incidence of spontaneous lymphocytic leukaemia lower than 5 per cent after 15 months of age. Spontan-
eous tumours of other types are also very rare, except in C3H female mice, over
80 per cent of which usually develop mammary tumours after 8 'Months.
The Aki strain originally obtained from Dr. J. Furth via Professor J. Engel- breth-Holm, has been inbred here since 1945 and shows a high incidence of245 THYMUS HOMOGRAFTS IN IMMUNOLOGICALLY TOLERANT MICE
spontaneous lymphocytic leukaemia, about 90 per cent of the mice developing
the disease at approximately 9 months of age (Miller, 1960a).
-Induction ofimmunological tolerance.-Cell suspensions from thymus or spleen
of one-month-old Ak or C3H donors were prepared by teasing out the organ in
buffered Ringer phosphate solution, washing twice, and resuspending to the
volume at which 0-05 ml. of the suspension contained 5 to 8 million cells. This
amount was injected intravenously into new-born C3H or Ak mice, respectively,
less than 20 hours after birth. The technique of injecting the orbital branch of
the anterior facial vein or the sigmoid sinus of the new-born mouse has been
described and illustrated in the papers ofBillingham and Brent (1956, 1959) and
in a recent article by Brent (1959).
Marrow was expelled from the shafts of the femurs with a jet ofRinger phos-
phate through a No. 14 gauge needle mounted on a syringe. Gentle agitation by
suction in and out of a pipette allowed the cells to separate from one another.
They were then washed twice and resuspended so that each new-born mouse
received about 8 million cells.
Thymectomy and thymus grafting.-Thymectomy was performed at 3 to 0-
weeks ofage as describedpreviously (Miller, 1960b). Eachthymectomized mouse
was given a subcutaneous graft of a whole thymus from an untreated new-born
C3H or Ak female mouse, as required, on the day of thymectomy. Thymuses
from new-born mice were removed aseptically and introduced by a sterile trocar
into the subcutaneous tissues of the right (C3H thymuses) or left (Ak thymuses)
axilla. The mice were thereupon given 3000 to 4000 units ofpenicillin and 3 to
5 mg. ofstreptomycin daily for about 10 days to guard against infection.
Skin grafts.-Skin grafts from 1- to 2-month-old female Ak or C3H mice were
transplanted to 6- to 8-week-old C3H or Ak mice by the method of Billingham
and Medawar (1951) to provide an external indicator of the tolerant state.
Adoptive immunization.-The immune state may be acquired in three ways:
(1) actively, by the introduction of an antigen into the animal, (2) passively,
by the introduction of antibody prepared in another animal, and (3) by the
transfer of immunologically activated cells from one animal to the other.
Bifingham, Brent and Medawar (1954) have named the state of immunity
acquired in this third way
" adoptive
" immunity.
Normal 2-month-old C3H female mice were immunized against normal Ak
tissues. Each C3H mouse was given bilateral skin grafts and an intraperitoneal
injection of cells from two thymuses and two spleens from 1- to 2-month-old
healthy Ak donors. Ten to eleven days later, at a time when the reaction in the
skin graft was most intense, the mice were killed, and cell suspensions were
prepared from their axillary and inguinal lymph nodes and spleen. The cells
were immediately injected intraperitoneally into C3H mice tolerant of Ak to
abrogate tolerance. Each tolerant host received cells from twospleens and twelve
regional lymph nodes. These injections were repeated at intervals of 5 to 7
days as often as required.
Passage A filtrate.-This most powerful leukaemogenic filtrate was prepared from leukaemic mice oftheC3Hf/Gs strain as describedpreviously (IvEller, 1960a). It was injected intraperitoneally (0-2 to 0-3 c.c.) into 3- to 5-day-old mice, as
required, the needle first traversing the thigh muscles to avoid leakage. Transplantation of tumours.-CeR suspensions were prepared from leukaemic
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million cells. This was injected intraperitoneally into untreated adult C3H and
Ak mice. Small pieces of leukaemic thymus were introduced aseptically by
trocar under the skin in some of the mice.
Histology.-Sections were fixed in Bouin's fluid and stained in haematoxylin
and eosin or other stains when indicated.
EXPERIMENTAL
Experiments were performed on both Ak mice tolerant of C3H and on C3H
mice tolerant ofAk. The former were divided into three groups according to the
nature of the cells injectecl intravenously at birth. Group I received C3H or
C3Hf thymus cells, group 2, C3H spleen cells and group 3, C3H marrow cells.
Some of the mice in group I also received an injection of Passage A filtrate,
usually 3 to 5 days after birth. When inoculated as late as 14 days after birth
(Miller, 1960a) this filtrate causes leukaemia to develop within 3 to 6 months in
100 per cent of non-thymectomized mice of the Ak strain (Miller, 1960a). All
the mice werethymectomized at 3 to 5 weeks ofage. Ingroup 1,they weregrafted
subcutaneously with a day-old C3H or C3Hf thymus. In groups 2 and 3 they
received isologous thymus grafts.
C3H mice made tolerant of Ak were divided into two groups. Mice in both
groups were thymectomized but those in group I were grafted with day-old Ak
thymuses while those in group 2 were grafted with day-old C3H thymuses.
EXPLANATION OF PLATES
FIG. I.-Normal subcutaneous C3H thymus graft in an Ak mouse tolerant of C3H. This
section was made 60 days after grafting.
FIG. 2.-Mammary adenocareinoma in an Ak female mouse which received C3H marrow
cells at birth.
FIG. 3.-Malignancy in a subcutaneous Ak thymus grafted to a tolerant C3H mouse.
FIG. 4.-High power view of leukaemic lymphocytes in thymus graft seen in Fig. 3. Note
numerous mitoses.
FIG. 5.-Normal salivary gland tissue separated by a thin connective tissue capsule from the
parotid gland tumour. Note the resemblance between the norinal salivary ducts and the
duct-like elements of the tumour.
FIG. 6.-Another salivary gland tumour showing clearly the duct-like pattem plus the loose
mesenchymal elements.
RiG. 7.-A more solid type ofsalivary gland tumour. Note the adenomatous pattem merging into a confluent mass of cells.
FIG. 8.-High power view of asalivarygland tumour. Numerous mitoticfigures are seen. The
cells still show some grouping into glandular elements.
FIG. 9.-A pleomorphic sarcoma. Note the tumour giant cells and undifferentiated pattem of this tumour.
FIG. IO.-High power view of sarcoma seen in Fig. 9 to emphasize the nuclear variation and
numerous mitoses.
FIG. II.-A fibrosarcoma infiltrating skeletal muscle.
FIG. 12.-A tumour from the upper eyelid. Note the well-differentiated pattern and bundles
of uniform cells.
FIG. 13.-A necrotic anaplastic carcinoma. The grouping of the cells into clumps and the
degenerative changes are clearly shown.
FIG. 14.-Akidney from a mouse with bilateral parotid tumours. Note the irregular lympho- cytic infiltration in the cortex.
FIG. 15.-High power view ofkidney shown in Fig. 14. Note the normal small lymphocytes grouped around blood vessels and the absence of mitoses.BRITISH JOURNAL OF CANCER. Vol. XIV, No. 2.
I
2
3
Miller.BRITISH JOURNAL OF CANCER. Vol. XIV, No. 2.
PO
a 6
7 8
9 10
Miller.BRITISH JOURNAL OF CANCER. Vol. XIV, No. 2.
if 12
13 14
15
Millet.247 THYMUS HOMOGRAFTS IN IMMUNOLOGICALLY TOLERANT MICE
RESULTS
The results are presented in Tables I to V.
Induction ofimmunological tolerance in C3H or Ak mice
Tolerance of Ak skin grafts in C3H mice injected at -birth with Ak spleen or
thymus cells has already been described (Afiller, 1960a) and the results are re-
peated here for comparison with tolerance of C3H skin grafts in the Ak strain.
Up to 90 per cent of C3H mice were tolerant for periods up to a year or more.
There was no evidence that spleen cells were more effective than thymus cells
in inducing tolerance as they appeared to be in the strain combination used by
Billingham and Brent (1959). Injection of C3H spleen, thymus or marrow cells
in Ak new-born mice induced tolerance of C3H skin grafts in 70 to 80 per cent
of the mice (Table 1). The skin grafts were intact for a period of 4 to 6 months,
TABLE I.-Tolerance of Skin Grafts in Mice Inoculated at Birth with 5 to 8 million
Spleen, Thymus or Marrow Cells
Strain of I.V.I. given at birth Niunber
recipient
A in Number of mice
mice Donor strain Cell type group fully tolerant
C3H/PW Aki Spleen 143 128 (89%)*
or Thymus 161 137 (85%)*
C3HfJPW No cells 57 0 (0%)t
C3H/PW Thymus 75 51 (68%)t
Aki or Spleen 27 18 (67%)t
C3Hf/PW Marrow 32 26 (82%)l
No cells 30 0 ( 0%)§
Ak skin graft intact for a total period of observation of 12 to 18 months.
t Ak skin graft rejected in 10 to 12 days.
t C3H skin graft intact for 4 to 6 months (see text).
§ C3H skin graft reiected in 9 to 11 days.
but thereafter the hair in some of the grafts began to fade in colour and diminish
in thickness leaving agreyish-whitepatch. There was, however, no reaction such
as is characteristically in skin grafted to non-tolerant mice. Ten Ak mice not
included in Table 1, inoculated at birth with C3H thymus cells, were runts and
died before 5 weeks of age.
Tolerance of thymus homografts was evident from sections made of such
grafts 30 or more days after grafting (Fig. 1). Such thymuses showed intact
morphology. Thymus grafts in tolerant mice could often be made out ag small
subcutaneous nodules in or under the axilla when the overIvina skin was stretched.
The development o lymphocytic leukaemia and other tumours in Ak mice tolerant
of C3H
It can be seen from Table II that only one thymectomized Ak mouse grafted
with C3H thymus developed leukaemia. At autopsy the lymph nodes, including the paratracheal nodes, were involved and the liver and spleen were extensively infiltrated. There was no evidence of incomplete thymectomy. The sub-
cutaneous C3H thymus graft could not be found. On transplantation, the leu-
kaemia grew only in Ak mice and not in non-tolerant C3H mice, suggesting that
it had originated from lymphoid cells of the thymectomized Ak host.
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TABLIF, II.-Incidence of Mammary Tumours and Lymphomas in Aki Mice
Inoculated at Birth with Thymus, Spleen or Marrow Cells from Adult C3HIPW
or C3HfIPW Mice*
Mice with mammary Mice with lymphocytic
I.V.1. cells tumours neoplasms
at birth Number -A.
r
r in Age m Age in
Groupt Type Strain group Sex Number months % Number months /0O/
16 9 6-12 56 0 0
C3H (average 9)
1 Thymus 20 0 0 1 14 5
C3Hf 7t 0 0 0 0
4t 0 0 0 0
f5 2 12,14 40 3 7-9i 60
2 Spleen C3H (average8)
11 CT 0 0 9 6J-15 82
(average 9)
6 2 9, 10 33 4 6--8J 66
3 Marrow C3H (average 7)
1 0 0 9 5-10 82
(average 8)
Total period of observation 18 months.
t Mice in all groups were thymectomized. Those in group I were grafted subcutaneously with
C3H or C3Hfday-old thymuses. Those in groups 2 and 3 were grafted subcutaneously with isologous
thymuses and received 3 further injections of spleen and marrow cells, respectively, at 4, 6 and 8
weeks of age.
$ These mice received in addition to C3Hf thymus cells, an injection ofPassage A filtrate 3 to 5
days after birth.
None of the other mice in group I developed leukaemia or lymphoid tumour
in the thymus graft, not even those inoculated with Passage A. On the other
hand, half the female mice injected at birth with normal C3H (but not C3Hf)
thymus cells developed mammary carinomas (Fig. 2). Only one such tumour
has been seen in over a hundred non-tolerant Ak female mice the life ofwhich had
been proloiiged by thymectomy. None has ever been seen in intact Ak female
mice of our colony.
Mice in groups 2 and 3 which were thymectomized and grafted with isologous
thymuses developed lymphocytic leukaemia at approximately the age and fre-
quency characteristic of the Ak strain. In mo'st cases the subcutaneous Ak
thymus graft was involved. Repeated injections of C3H spleen or marrow cells
failed to alter the incidence. Some of the female mice in these two groups also
developed mammary carcinomas.
Incidence oflymphoid and other tunwurs in C3H mice tolerant of Ak
The incidence of tumours in thymectomized C3H mice tolerant of Ak and
bearing Ak or C3H'thymus grafts is shown in Table 111.
In group I (C3H mice bearing A-k thymus grafts) 14 mice developed lympho-
ey-ticneoplasms. In 10 the firstsign wasprogressiveenlargement at the site ofthe
subcutaneous thymus graft. In the other 4, generalized lymph node involve-
ment was evident from the onset and the graft was involved by the leukaemic
process in only two. One C3H mouse, not included in Table III because it had
rejected an Ak skingraft on two occasions, developed a tumour in the axilla which
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TABLE III.-IncidenceofLymphomasandOther Tumours in C3HIPW orC3HfIPW
mice tolerant of Ak tissues and Bearing either Aki or Isologous Thymus Grafts*
Mice with lymphomas Mice with other tumours
Thymus Recipient
A
-1 r- -
A_
Groupt donor strain Number Sex Number Age in months Number Age in months Type
r29 6 5-16 9 (7-11) M.T.
C3H (average 9)
1 Aki 29 5 5-8 0
(average 5
-6)
C3Hf 17 2 9, 10 7 (5-7) SGT, SA
22 1 10 4 (6-8) SGT, CA
TOTAL 97 14
C3H rC3H 6 0 4 (7-12) M.T.
2 or
C3Hf C3Hf 7 0 0
6 0 0
TOTAL 23 0
Total period of observation 16 to 20 months.
t Mice in group I were injected at birth with normal Ak spleen or thymus cells, thymectomized
and grafted with a day-old Ak thymus. Mice in group 2 were treated as those in grolip I except that
they were grafted with a day-old C3H thymus.
M.T. = mammary tumours.
SGT = salivary gland tumours
SA = sarcoma described in text.
CA = carcinoma
The histological appearance of a typical lymphoid tumour arising in a thymus
graft is shown in Fig 3 and 4.
None of the mice in group 2 (tolerant C3H mice bearing C3H thymus grafts)
developed lymphocytic neoplasms.
The C3H females in both groupsdeveloped mammary carcinomas characteristic
of the C3H strain. Eleven mice in group 1, however, unexpectedly developed a
whole array of tumours which are described below. It is significant that these
eleven mice were survivors from two litters injected on the same day with the
same preparation of a mixture of normal Ak spleen and thymus cells, and that
they were not inoculated with Passage A or other leukaemogenic filtrate.
Immunogenetic behaviour oflymphoid tumours arising in C3H mice tolerant of Ak
The lymphoid tumours developing in tolerant C3H mice were transplanted to
both Ak mice and non-tolerant C3H adult mice (Table IV). Five were trans-
plantable to both Ak and C3H, two grew only in A_k, and five, curiously enough,
only in C3H. Four of the latter had originated when their host was 10 months
old or older and one at 6 months of age, after the host had spontaneously rejected
the Ak skin graft.
Fate oflymphoid tumours in thymus homograftsfollowing adoptive immunization
Malignancy in the subcutaneous thymus homografts became evident with
the progressive enlargement of the graft. An attempt was made to abrogate
tolerance in seven mice which had developed a tumour in the graft by using lym-
phoid cells from non-tolerant C3H mice which were previously sensitized against
normal tissues (Table V). Treatment was commenced when the grafts had
reached half a centimetre in the largest diameter. The tumour completely
regressed in three out ofthe seven treated mice. This waspreceded by an intenseResults oftransplantation by cells
A t
In strain oforigin
r- I
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TABLE IV.-Transplantation of Lymphocytic Neoplasms Arising in C3H Mice
Tolerant of Ak, Thymectomized and Bearing Subcutaneous Ak Thymus Grafts
Leukaemic donor
r- -.A-
I -I
In Ak stra'm
r
Result Latency (days)
0/6
0/6
6/6 20-30
4/4 24-36
2/6 36, 41
4/4 18-30
0/4
3/3 20-25
0/3
4/4 22-29
3/4 26-32
0/4
Age in
months at
sacrifice
12
16
5
9
9
5
10
8
10
7
5
6
Number
1
2
3
4
5
6
7
8
9
10
14
15T
Sex
y
y
CT
y
y
y
CT
d
y
y
d
y
Result*
4/6
3/6
0/6
4/4
3/3
0/4
3/5
3/3
3/4
3/5
2/4
4/4
Latencyt (days)
21-40
41-48
30-38
34-38
31-47
27-31
36-47
20-31
31, 33
25-39
* Numerator = number oftakes; denominator = number of animals.
t Interval between grafting and sacrifice or death.
t This mouse is not included in Table III because its tumour arose after it had rejected the Ak
skin graft.
The first evidence ofmalignancy in mice Nos. 3, 4, 5, 6, 8, 10, 14 and 15 was enlargement at the
site of the thymus graft.
TABLE V.-Effect of Immune C3H Cells on L,ymphoid Tumour Growth in C3H
Mice TolerantofAk
Transplantation
Age at Interval in days between results (Table IV)
o set of -..A- r- I
malignancy diagnosis* and diagnosis Takes Takes
Number Sex (months) Ist treatment and death in Ak in C3H
6 5 16 27 +
8 8 1 24 + +
10 7 14 31 + +
11 5 18 t Not done
12 5 3 t
13 6 1 t
14 CT 5 1 27 + +
* The day of diagnosis was arbitrarily fixed as the day when the enlargement of the graft had
reached half a centirnetre in its largest diameter.
t Tumour in thymus graft completely regressed from 20 to 40 days after first treatment with
inunune cells.
reaction in the skingraftduring the second week after the firstinjection ofimmune
cells. No signs ofgeneralized leukaemia were ever present in these three mice.
The other four mice all succumbed to the disease. A feeble skingraft reaction
was observed inonly two and signs ofdissemination ofthe disease became evident
during the first or second week of treatment. The mice were killed when it
became obvious that the treatment had failed, and the tumours were trans-
planted. As seen from Table IV, only one of these tumours took only in Ak.
The other three were transplantable to both Ak and C3H.
The development ofparotid and other tumours in C3H mice inoculated at birth with
normal Ak spleen and thymus cells
The most unexpected regult of the present experiments was the occurrence of
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tumours in eleven C3Hf mice from two litters inoculated at birth with the same
suspension of normal Ak spleen and thymus cells (Fig. 5-15). Most of the mice
had salivary gland tumours on both sides (either both parotids or one parotid
and one sublingualgland being involved). One mouse had threeprimary tumours
(one parotid gland tumour, one sarcoma in the pectoral muscles and one sarcoma
in the thigh muscles).
All the parotid tumours examined showed essentially the same structure.
Macroscopically they were made up of discrete nodules, firm, opaque, yellowish-
white and of rubbery consistency. Microscopically, a thin fibrous capsule could
be seen in some places only with the growth expanding and compressing it.
Outside the capsule was some lymphocytic infiltration. Two main types of
structure were found in the tumour proper: duct-like structures very similar
to the normal ducts ofthegland (Fig. 5) and a uniformpopulation ofmesenchymal-
like cells with oval nuclei and delicate cytoplasmic processes. Fig. 6 shows both
these patterns while Fig. 7 shows a more solid growth in which the adenomatous
pattern merges into a confluent mass of cells. Under the high power (Fig. 8)
many mitoses were seen in both the duct and mesenchymal cells. There were no
necrotic or degenerative changes in the tumour as a whole.
Several inice had sarcomatous tumours growing in muscle tissue. These
tumours were whitish-pink solid circumscribed masses without necrosis. The
histological features of two such tumours are shown in Fig. 9-11. One of the
tumours was in the pectoral muscles and showed much individual cellular varia-
tion (Fig. 9 and 10). Most of the cells were large with big nuclei and a greatly
increased nuclear-cytoplasmic ratio. Tumour giant cells were plentiful and
mitoses frequent. Cell boundaries were hard to see in some areas and a diffuse
syncytium was present. Many new blood spaces could be seen and invasion of
muscle tissue was evident. No cross-striation could be found in the tumour cells
when the sections were stained with phosphotungstic acid haematoxylin and the
tumour was best described as un undifferentiated anaplastic sarcoma. Another
sarcoma in the same mouse was growing in the muscles of the thigh. The cells
were mostly fusiform (Fig. 11). The nuclei were oval and only an occasional
giant cell was present. The growth could be seen invading skeletal muscle and
was richlysupplied with new, thin-walled, blood vessels. Fine fibrils ran betweeii
individual cells and special stains showed that the tumour cells were producing
a considerable amount ofcollagen. The tumour was undoubtedly a fibrosarcoma.
One mouse had a bilateral parotid tumour and tumours growing in both upper
eyelids (Fig. 12). These latter were excised when they reached about half a
centimetre in diameter and appeared to consist mostly of fibrous tissue. Histo-
logically, they were well-differentiated growths underlying normal epidermis.
They were characterized by bundles of uniform cells running in an interlacing
pattern with some palisading of their nuclei although this was not well marked.
Under the high power there was more nuclear variation than would be expected
for a benign neurofibroma. Also many more mitotic figures were present,
suggesting the histological diagnosis of fibrosarcoma oflow-grade malignancy.
One mouse had a tumourgrowing in the abdominal cavity. It was a spherical
mass with black and red patches of necrosis and haemorrhage, attached to the
upper pole of the left kidney and about the same size as the kidney itself. The
left adrenal could not be found. Microscopically (Fig. 13) undifferentiated cells
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vessels and tumour emboli were evident inplaces and areas ofnecrosis and haeinor-
rhage werefrequent. The tumour wasdiagnosed as an undifferentiatedanaplastic
carcinoma.
No proliferative or nuclear changes were observed in the renal tubules such
as has been described in mice inoculated with the polyoma virus (Stewart, Eddy
and Stanton, 1959 ; Stanton et al., 1959). There was an irregular lymphocytic
infiltration in the cortex of one kidney, many small round cells being grouped
mostly around small blood vessels. No inflammation was seen in the renal tubules
nor was there any otber evidence of pyelonephritis. The cells, themselves,
appeared to be normal smalllymphocytes (Fig. 14, 15) and no mitoses were found.
There was no evidence of any leukaemic process anywhere in the animal.
Much of the above histological description was very kindly supplied by Dr.
P. M. Sutton to whom I am very grateful.
DISCUSSION
It has been observed in the experiments reported here that high-leukaemic
strain Ak. mice which had been made immunologically tolerant of C3H tissues
and which had been thymectomized and grafted with C3H thymus tissue did not
develop lymphocytic leukaemia or lymphoid tumours in the graft. These mice
are said to contain aleukaemogenic agent (Gross, 1958) and some ofthemreceived,
soon after birth, aninjection ofPassage A filtrate, wbich has been shown to accele-
rate the onset of the disease in intact Ak mice (Miller, 1960a). Yet, in spite of
the presence in a genetically predisposed strain of both thymus tissue (genetically
foreign but tolerated) and leukaemic agent, the disease failed to develop. On
the other hand, low-leukaemic thymectomized C3H mice tolerant ofAk and bear-
ing subcutaneous grafts of normal new-born Ak thymus developed lymphocytic
leukaemia or malignancy in the graft as early as 5 months after birth. The mice
received noinjection ofleukaemogenic filtrate at birth although they wereinjected
with normal Ak cells. However, we have failed to demonstrate that such an
injection ofcells, per 8e, produced leukaemia in tolerant thymectomized C3H mice
bearing isologous thymus grafts (Table 11) or in tolerant C3H mice with intact
thymuses (Miller, 1960a). Clearly, therefore, the genetic susceptibility to leu-
kaemia development must depend on an intrinsic property of the thymus tissue
itself. The results obtained here are in accordance with those of Law (1952, 1957)
who showed that
" genetically tolerant
" F, hybrids from crosses between high
and low leukaemic strains, bearing thymusgrafts from the low leukaemic parental
line, did not show neoplastic change in the grafted thymus, whereas those receiv-
ingthymusgrafts from thehigh leukaemicparental linedeveloped ahigh incidence
of lymphocytic neoplasms in the graft. In similar experiments, Kaplan, Hirsch
and Brown (1956) showed that C57BI, but not C3H, thymic implants developed
lymphoid tumours in irradiated thymectomized (C-57BI x C3H)F1 hosts.
There are clearly two possible ways by which the presence of an Ak thymus
in a tolerant C3H host could lead to the occurrence oflymphocytic neoplasnis in
the host. Either (1) the Ak thymus is a source of potentially malignant Ak
lymphocytes which can undergo neoplastic transformation either in their own
host or in a genetically foreign but tolerant host ; or (2) a non-cellular influence
from the Ak thymus is responsible for the malignant change.
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which developed in tolerant C3H mice would be transplantable to Ak mice.
Two of the early neoplasms were undoubtedly of Ak origin, growing only in Ak
mice, and those that regressed following injection of sensitized lymph node and
spleen cells must presumably also have been of Ak origin. The behaviour of the
5 neoplasms which grew both in Ak and C3H could be explained by reference to
previous work which showed that a certain percentage of Ak leukaemias would
take in C3H (Furth, Boon and Kaliss, 1944) orthat, by transformation or immuno-
selection or both, a single passage of a tumour through a tolerant foreign host
allowed subsequent growth in untreated adult mice of theforeign strain (Koprow-
ski, Gail andLove, 1956). Finally, the fiveneoplasms that grewonly in C3H could
be spontaneous C3H neoplasms that would have developed whether the Ak
thymus was present or not. At least the one arising at 16 months islikely to have
been a spontaneous neoplasm. The disease is, however, rare before 12 months
of age and only 2 cases have been diagnosed at 12 and 14 months in 227 untreated
mice observed for a period of 14 months (Miller, 1960a).
The second hypothesis assumes that a malignant change takes place in a
population of lymphocytes, host or donor, as a result of a non-cellular influence
from the thymic epithelial reticulum cells of the Ak donor. The lymphocytic
population of the compatible graft (Ak) in the genetically different but tolerant
host (C3H) might undergo a change, donor-type lymphocytes being gradually
replaced by host lymphocytes. On the other hand, the reticular tissue of the
donor thymus might survive and induce neoplastic transformation in either
donor or infiltrating host lymphocytes. This may account for the fact that most
of the early neoplasms were Ak in type and the later ones C3H. Again, this
situation is similar to that described by Law (1952) and Law and Potter (1956).
In their experiments, AKR thymus fragments increased the incidence of leu-
kaemia in (C3Hb x AKR)F1 hosts, the resulting neoplasm beino, transplantable
only to F, hosts. In another hybrid combination, susceptible to the leukaemo-
genic activity of X-irradiation, malignancy developed in thymuses from unir-
radiated C57BI donors grafted to irradiated (C57BI x A)F1 hosts. The tumours
developing early (at about 5 months) were found to be contributed by descendants
of donor C57BI thymus tissue whereas those arising later (7-10 months) were
found to have originated from F, host cells which must have populated the graft.
The transfer ofimmunity against homografts of skin and transplantable tum-
ours by lymph node cells ofactively immunized mice has been described by many
authors (Potter, Taylor and MacDowell, 1938; MacDowell et al., 1938; Brncie,
Hoecker and Gasic, 1952; Mitchison, 1953, 1954; Billingham, Brent and
Medawar, 1954, 1956; Koprowski et al., 1956). By using activated lymphoid
cells, Medawar and Russell (1958) showed that tolerant adrenalectomized mice
making use ofhomografts of adrenal cortical tissue could in effect be adrenalecto-
mized, and similar results have been obtained by Krohn (1960, persolial communi-
cation) with orthotopic homografts of ovaries. In three out of seven experiments
described here C3H lymphoid cells sensitized against normal Ak tissues success-
fully caused immunologically tolerant C3H hosts to reject normal Ak skin, and
Ak thymus after neoplastic transformation. One of the tumours that failed to
be rejected was transplantable only to Ak mice and it is li'l-Cely that the disease
was too advanced when treatment was commenced. The other three tumours
that could not be made to regress presumably acquired the ability to overcome
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they grew perfectly well in both non-tolerant adult C3H hosts and in Ak
mice.
The development of spontaneous leukaemia was not retarded nor was the
incidence lowered in tolerant Ak mice given repeated injections of marrow or
spleen cells from low-leukaemic C3H mice. A retarding effect of C3H marrow
on the development of spontaneous lymphomas in (AKR x C3H)F1 hybrids has
beenreported by Lorenz, Law and Congdon, (1954). It is possible that this effect
is not demonstrable in the pure strain.
The occurrence of sahvary and other tumours in tolerant C3H mice and of
mammary tumours in tolerant Ak mice was unexpected. Only Ak females that
had received C3H and not C3Hf cells developed breast tumours, which suggests
transfer ofthe Bittner agent at birth via the cells. The C3Hfmice that developed
salivary and other tumours all came from two litters injected on the same day
with the same preparation of normal Ak cells; all the surviving members of the
two litters were affected. None received leukaemogenic filtrate. This particular
distribution, the variety of the tumours, and the fact that the animals had all
been injected on the first day of life with the same preparation of cells strongly
suggests that the cells were obtained from Ak mice carrying the polyoma virus
known to be present in various Ak stocks (Rowe et al., 1959). Neither tissue
culture (Stewart et al., 1957) nor high speed centrifugation (Buffett et al., 1958)
is thus necessary to disclose the multipotentiality of this agent.
SrMMARY
1. Acquired tolerance of C3H and A-k thymus homografts has been achieved
in Ak and C3H mice, respectively, by the intravenous injection at birth of C3H
and Ak thymus or spleen cells.
2. LymphocyticneoplasmsdevelopedinAkthymusesgrafted tothymectomized
tolerant C3H mice. None were, however, seen in C3H thymuses grafted to thy-
mectomized tolerant A-k mice.
3. The lymphocytic neoplasms arising in tolerant C3H mice were in some
cases transplantable only to A-k mice, in others to both Ak and non-tolerant
adult C3H and in others only to non-tolerant C3H.
4. Three out of seven lymphoid tumours developing at the site of the Ak
thymus graft in tolerant C3H mice completely regressed after treatment of the
host with C3H lymphoid cells from mice previously sensitized against normal
Ak tissues.
5. Other tumours occurred in these experiments. Tolerant Ak female mice
developed mammary carcinomas. A group of tolerant C3H mice injected at
birth with the same preparation of normal Ak cells developed multiple salivary
gland tumours and other tumours.
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